Epigenetic drugs can increase tumour malignancy
In Nature Cell Biology the team headed by Salvador Aznar Benitah and Fran Supek reported that genetic inactivation of histone H3...
Hitachi expands European reach in cell and gene therapy
Under the terms of the agreement, Hitachi will pay €75.5m to acquire all assets form apceth's shareholders Santo Holding GmbH (82.49%), FCP...
Sugar replacement slows cancer growth
Feeding mannose either alone or alongside chemotherapy through a feeding tube three times a week and continuously via their drinking water was...
Forbion leads €40m financing in Inflazome Ltd
Inflazome said it will use the proceeds to develop its small molecule NLRP3 inflammasome inhibitor to clinical proof-of-concept in several chronic...
Cellestia Biotech AG attracts Series A financing
The company, which is in Phase I testing of CB-103 in 25 patients with advanced blood cancers and solid tumours, said it will use the proceeds to...
EMA greenlights two orphan drugs and two biosimilars
Two of six new meds to be approved in Europe are biosimilar medicines and have been backed by the European Medicines Agency (EMA) this...
Diabetes doubles risk for heart failure
Recent clinical trials of new glucose-lowering treatments have drawn attention to the importance of hospitalization for heart failure as a...